BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34609422)

  • 1. The immunoexpression of epidermal growth factor receptor in cutaneous squamous cell carcinoma.
    Nichita MM; Giurcăneanu C; Mihai MM; Ghigulescu M; Beiu C; Negoiţă SI; Popa LG
    Rom J Morphol Embryol; 2021; 62(1):201-208. PubMed ID: 34609422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
    Uribe P; Gonzalez S
    Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor expression is associated with poor outcome in cutaneous squamous cell carcinoma.
    Cañueto J; Cardeñoso E; García JL; Santos-Briz Á; Castellanos-Martín A; Fernández-López E; Blanco Gómez A; Pérez-Losada J; Román-Curto C
    Br J Dermatol; 2017 May; 176(5):1279-1287. PubMed ID: 27510450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of EGFR in prognostic characterization in histopathological variants of oral squamous cell carcinoma.
    Tyagi D; Singhal M; Gulati N; Jain A; Shetty DC
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S743-S746. PubMed ID: 38384049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma.
    Bernat-Peguera A; Navarro-Ventura J; Lorenzo-Sanz L; da Silva-Diz V; Bosio M; Palomero L; Penin RM; Pérez Sidelnikova D; Bermejo JO; Taberna M; Vilariño N; Piulats JM; Mesia R; Viñals JM; González-Suárez E; Capella-Gutierrez S; Villanueva A; Viñals F; Muñoz P
    Clin Cancer Res; 2021 Mar; 27(5):1491-1504. PubMed ID: 33262138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of epidermal growth factor receptor in actinic keratosis and squamous cell carcinoma.
    Joseph SR; Endo-Munoz L; Gaffney DC; Saunders NA; Simpson F
    Curr Probl Dermatol; 2015; 46():20-7. PubMed ID: 25561202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual inhibition of epidermal growth factor receptor and insulin-like growth factor receptor I: reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma.
    Galer CE; Corey CL; Wang Z; Younes MN; Gomez-Rivera F; Jasser SA; Ludwig DL; El-Naggar AK; Weber RS; Myers JN
    Head Neck; 2011 Feb; 33(2):189-98. PubMed ID: 20848439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of p53, c-erbB-2 and epidermal growth factor receptor on head and neck carcinoma.
    Parise Junior O; Carvalho LV; Miguel RE; Kowalski LP
    Sao Paulo Med J; 2004 Nov; 122(6):264-8. PubMed ID: 15692721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters.
    Hashmi AA; Hussain ZF; Aijaz S; Irfan M; Khan EY; Naz S; Faridi N; Khan A; Edhi MM
    World J Surg Oncol; 2018 Jun; 16(1):118. PubMed ID: 29954411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes.
    Seethala RR; Gooding WE; Handler PN; Collins B; Zhang Q; Siegfried JM; Grandis JR
    Clin Cancer Res; 2008 Mar; 14(5):1303-9. PubMed ID: 18316548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vandetanib inhibits cell growth in EGFR-expressing cutaneous squamous cell carcinoma.
    Kitamura S; Maeda T; Yanagi T
    Biochem Biophys Res Commun; 2020 Oct; 531(3):396-401. PubMed ID: 32800552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current challenges and clinical investigations of epidermal growth factor receptor (EGFR)- and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma (HNSCC).
    Cohen RB
    Cancer Treat Rev; 2014 May; 40(4):567-77. PubMed ID: 24216225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of advanced cutaneous squamous cell carcinomas with epidermal growth factor receptor inhibitors.
    Alter M; Satzger I; Mattern A; Kapp A; Gutzmer R
    Dermatology; 2013; 227(4):289-94. PubMed ID: 24217470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal Growth Factor Receptor Expression in Spindle Cell Carcinomas of the Head and Neck.
    Watson RF; Chernock RD; Zhang KH; Michel LS; Adkins DR; El-Mofty SK; Lewis JS
    Head Neck Pathol; 2015 Sep; 9(3):360-8. PubMed ID: 25563452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus, p16, and epidermal growth factor receptor biomarkers and CT perfusion values in head and neck squamous cell carcinoma.
    Hoefling NL; McHugh JB; Light E; Kumar B; Walline H; Prince M; Bradford C; Carey TE; Mukherji SK
    AJNR Am J Neuroradiol; 2013 May; 34(5):1062-6, S1-2. PubMed ID: 23370473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma.
    O'Bryan K; Sherman W; Niedt GW; Taback B; Manolidis S; Wang A; Ratner D
    J Am Acad Dermatol; 2013 Oct; 69(4):595-602.e1. PubMed ID: 23871719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
    Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
    Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal Growth Factor Receptor's Function in Cutaneous Squamous Cell Carcinoma and Its Role as a Therapeutic Target in the Age of Immunotherapies.
    de Lima PO; Joseph S; Panizza B; Simpson F
    Curr Treat Options Oncol; 2020 Feb; 21(1):9. PubMed ID: 32016630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoexpression of EGFR and EMMPRIN in a series of cases of head and neck squamous cell carcinoma.
    de Andrade AL; Ferreira SJ; Ferreira SM; Ribeiro CM; Freitas Rde A; Galvão HC
    Pathol Res Pract; 2015 Oct; 211(10):776-81. PubMed ID: 26296920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR expression in advanced head and neck cutaneous squamous cell carcinoma.
    Sweeny L; Dean NR; Magnuson JS; Carroll WR; Helman EE; Hyde SO; Desmond RL; Rosenthal EL
    Head Neck; 2012 May; 34(5):681-6. PubMed ID: 21739514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.